| 000 | 01391 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250514231732.0 | ||
| 264 | 0 | _c20060119 | |
| 008 | 200601s 0 0 eng d | ||
| 022 | _a0022-3549 | ||
| 024 | 7 |
_a10.1002/jps.20392 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKortejärvi, H | |
| 245 | 0 | 0 |
_aBiowaiver monographs for immediate release solid oral dosage forms: ranitidine hydrochloride. _h[electronic resource] |
| 260 |
_bJournal of pharmaceutical sciences _cAug 2005 |
||
| 300 |
_a1617-25 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aBiopharmaceutics |
| 650 | 0 | 4 | _aCaco-2 Cells |
| 650 | 0 | 4 | _aDatabases, Bibliographic |
| 650 | 0 | 4 | _aDosage Forms |
| 650 | 0 | 4 | _aDrug Approval |
| 650 | 0 | 4 | _aExcipients |
| 650 | 0 | 4 |
_aHistamine H2 Antagonists _xchemistry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPermeability |
| 650 | 0 | 4 |
_aRanitidine _xadministration & dosage |
| 650 | 0 | 4 | _aSolubility |
| 650 | 0 | 4 | _aTherapeutic Equivalency |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aYliperttula, M | |
| 700 | 1 | _aDressman, J B | |
| 700 | 1 | _aJunginger, H E | |
| 700 | 1 | _aMidha, K K | |
| 700 | 1 | _aShah, V P | |
| 700 | 1 | _aBarends, D M | |
| 773 | 0 |
_tJournal of pharmaceutical sciences _gvol. 94 _gno. 8 _gp. 1617-25 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/jps.20392 _zAvailable from publisher's website |
| 999 |
_c15618502 _d15618502 |
||